Why AVITA Medical Inc (RCEL) Stock Is Rising
As of 2026-07-17, AVITA Medical Inc (RCEL) has a next-year EPS growth estimate of 48.42%. Featured in our EPS revision report on 2026-07-17.
Why RCEL Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised AVITA Medical Inc's next-year EPS growth estimate from 48.39% to 48.42% on 2026-07-14.
- ·Current-Year Growth: Projected at 39.67%, supporting the forward estimate revision.
News Context
RCEL’s stock rise was primarily driven by an EPS growth estimate upgrade from 48.39% to 48.42% on July 14, 2026. This revision likely reflects the positive interim Cohealyx study results showing accelerated time to skin grafting, a product catalyst. Momentum may have been sustained by the upcoming second-quarter earnings announcement and the founder’s lifetime achievement award.
Generated 2026-07-17 · news as of 2026-07-17
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 48.42%
- EPS growth this year
- 39.67%
- EPS next quarter (est)
- -$0.29
- Last price
- $5.10
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-17 | 48.42% | 39.67% | -$0.29 | $5.10 |
| 2026-07-16 | 48.42% | 39.67% | -$0.29 | $4.98 |
| 2026-07-15 | 48.42% | 39.67% | -$0.29 | $4.73 |
| 2026-07-14 | 48.42% | 39.67% | -$0.29 | $4.02 |
| 2026-07-13 | 48.39% | 39.67% | -$0.29 | $3.95 |
| 2026-07-12 | 48.41% | 39.65% | -$0.29 | $4.06 |
| 2026-07-09 | 48.41% | 39.65% | -$0.29 | $4.41 |
| 2026-07-08 | 48.41% | 39.65% | -$0.29 | $4.65 |
| 2026-07-07 | 48.41% | 39.65% | -$0.29 | $5.00 |
| 2026-07-06 | 48.41% | 39.65% | -$0.29 | $5.19 |
| 2026-07-05 | 48.41% | 39.65% | -$0.29 | $5.06 |
| 2026-07-02 | 48.41% | 39.65% | -$0.29 | $5.06 |
| 2026-07-01 | 48.41% | 39.65% | -$0.29 | $4.67 |
| 2026-06-30 | 36.94% | 37.35% | -$0.30 | $4.13 |
| 2026-06-29 | 37.58% | 36.56% | -$0.31 | $4.25 |
| 2026-06-28 | 37.58% | 36.56% | -$0.31 | $3.97 |
| 2026-06-25 | 37.58% | 36.56% | -$0.31 | $3.92 |
| 2026-06-24 | 37.58% | 36.56% | -$0.31 | $3.95 |
| 2026-06-23 | 37.58% | 36.56% | -$0.31 | $3.92 |
| 2026-06-22 | 37.58% | 36.56% | -$0.31 | $4.03 |
| 2026-06-21 | 37.58% | 36.56% | -$0.31 | $4.01 |
| 2026-06-18 | 37.58% | 36.56% | -$0.31 | $4.01 |
| 2026-06-17 | 37.58% | 36.56% | -$0.31 | $3.94 |
| 2026-06-16 | 37.58% | 36.56% | -$0.31 | $3.92 |
| 2026-06-15 | 37.58% | 36.56% | -$0.31 | $3.93 |
| 2026-06-14 | 37.58% | 36.56% | -$0.31 | $3.91 |
| 2026-06-11 | 37.58% | 36.56% | -$0.31 | $3.97 |
| 2026-06-10 | 37.58% | 36.56% | -$0.31 | $4.12 |
| 2026-06-09 | 37.58% | 36.58% | -$0.31 | $4.12 |
| 2026-06-08 | 37.58% | 36.58% | -$0.31 | $4.16 |
Reports Featuring RCEL
Recent News
- AVITA Medical to Announce Second Quarter 2026 Financial ResultsGlobeNewswire
- AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn AssociationGlobeNewswire
- AVITA Medical Announces Positive Interim Results from Cohealyx Study Demonstrating Accelerated Time to Skin GraftingGlobeNewswire
Screen Performance
Aggregate stats across all 1864 tickers our top-EPS-revision screen has flagged over the past 107 days.
- Median return since detection
- +2.5%
- % of tickers in the green
- 55%
- Median return on winners
- +20.8%
- Large revisions captured
- 1048
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did AVITA Medical Inc (RCEL) stock go up recently?▾
AVITA Medical Inc (RCEL) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 48.39% to 48.42% on 2026-07-14. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is AVITA Medical Inc's next-year EPS growth estimate?▾
As of 2026-07-17, AVITA Medical Inc (RCEL) has a next-year EPS growth estimate of 48.42%, based on analyst consensus.
When was the latest EPS estimate revision for RCEL?▾
The most recent revision occurred on 2026-07-14, when analysts adjusted the next-year EPS growth estimate from 48.39% to 48.42%.
What sector and industry does AVITA Medical Inc belong to?▾
AVITA Medical Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. RCEL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. AVITA Medical Inc (RCEL) appears here because it was detected by our daily top-EPS-revision-performer screen.